Eisai
4523.T
#2340
Rank
A$11.73 B
Marketcap
A$41.58
Share price
0.34%
Change (1 day)
-14.67%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.21. In 2026 the company made an earnings per share (EPS) of A$1.21 a decrease over its 2025 EPS that were of A$1.53.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026A$1.21-21.04%
2025A$1.5311.85%
2024A$1.37-32.63%
2023A$2.035.52%
2022A$1.92-74.01%
2021A$7.39-66.58%
2020A$22.1298.24%
2019A$11.1617.01%
2018A$9.5437.78%
2017A$6.92-27.62%
2016A$9.5635.33%
2015A$7.07-2.82%
2014A$7.27-27.66%
2013A$10.05-27.49%
2012A$13.87-12.67%
2011A$15.8888.08%
2010A$8.44-11.06%
2009A$9.49-390.15%
2008A-$3.27-127.78%
2007A$11.78347.11%
2006A$2.634.38%
2005A$2.527.4%
2004A$2.3543.03%
2003A$1.6425.09%
2002A$1.3152.67%
2001A$0.8669.76%
2000A$0.51